<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00595855</url>
  </required_header>
  <id_info>
    <org_study_id>PARMASURG001</org_study_id>
    <nct_id>NCT00595855</nct_id>
  </id_info>
  <brief_title>A Comparison Between Deep Sclerectomy and Trabeculectomy</brief_title>
  <official_title>Deep Sclerectomy Versus Trabeculectomy. A 7 Year Prospective Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients affected by medically uncontrolled open angle glaucoma will be randomised to either
      a non penetrating procedure (deep sclerectomy) or conventional trabeculectomy. The longterm
      efficacy (i.e. IOP w/out therapy) and safety (i.e. visual acuity, visual field stability and
      co-morbidities) will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective 7-year randomised investigator -masked clinical trial 79 eyes (79 patients)
      enrolled randomised to surgery by PEX and previous pilocarpine use Deep sclerectomy n = 41
      Trabeculectomy n = 38 Estimated DS : TE success = 1:3 10% attrition ; power = 90%, alpha = 5%

      Methods and evaluation of outcomes:

        1. IOP: average of the two highest readings of the IOP phasing (6 readings)

        2. VA: LogMAR (ETDRS chart)

        3. Lens: LOCSII (slit lamp classification), worsening = one step progression confirmed at
           two visits

      study visits: every 4 months
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1997</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">January 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intra ocular pressure without therapy (% of eyes within pre-selected cut-off limits)</measure>
    <time_frame>7 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>(a) LogMAR visual acuity, (b) number of cataract extraction procedures</measure>
    <time_frame>7 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>TE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>trabeculectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>deep sclerectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trabeculectomy</intervention_name>
    <description>Cairns-like trabeculectomy, limbus based, with 5_FU supplementation and argon laser suturelysis</description>
    <arm_group_label>TE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>deep sclerectomy</intervention_name>
    <description>deep sclerectomy with no implant and no sutures to the superficial flap, limbus based with suppplementation of FU (if needed)</description>
    <arm_group_label>DS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angle wide open

          -  Age &gt; 65 yrs

          -  IOP &gt; 23 and &lt; 30 mmHg (average of the two highest readings of the daily IOP phasing)

          -  Topical beta blocker in fellow eye

          -  At least two medications in use + previous ALT

          -  MD &lt; 20 dB (HFA 24-2 full threshold)

          -  LOCSII &lt; C1-N1-P0
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gandolfi Stefano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Parma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sally Williams</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2008</study_first_submitted>
  <study_first_submitted_qc>January 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2008</study_first_posted>
  <last_update_submitted>January 7, 2008</last_update_submitted>
  <last_update_submitted_qc>January 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>STEFANO GANDOLFI, CHAIRMAN UNIV. EYE CLINIC</name_title>
    <organization>UNIVERSITY OF PARMA</organization>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>surgery</keyword>
  <keyword>non penetrating procedures</keyword>
  <keyword>cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

